96 related articles for article (PubMed ID: 1029989)
21. [Changes in peripheral arterial blood flow and venous capacity in arterial hypertension and their relationship to the antihypertensive action of beta blockers].
Caesar K; Saborowski F; Lang R; Meurer KA; Kaufmann W
Verh Dtsch Ges Kreislaufforsch; 1977; 43():218. PubMed ID: 613580
[No Abstract] [Full Text] [Related]
22. [Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance].
Greminger P; Vetter H; Boerlin HJ; Baumgart P; Havelka J; Walger P; Lüscher T; Siegenthaler W; Vetter W
Schweiz Med Wochenschr; 1982 Dec; 112(50):1831-5. PubMed ID: 7156966
[No Abstract] [Full Text] [Related]
23. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
[TBL] [Abstract][Full Text] [Related]
24. Effect of atenolol, a new cardioselective beta-blocker, on plasma renin activity in treatment of hypertension.
Balansard P; Chabrillat Y; Paulin R; Libes M; Gérard R
Acta Cardiol; 1977; 32(4):229-43. PubMed ID: 304291
[TBL] [Abstract][Full Text] [Related]
25. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
Teeuw AH; Leenen FH; Geyskes GG; Boer P
Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678
[TBL] [Abstract][Full Text] [Related]
26. Chronic atenolol treatment and hypertension development in spontaneously hypertensive rats.
Richer C; Boissier JR; Giudicelli JF
Eur J Pharmacol; 1978 Feb; 47(4):393-400. PubMed ID: 631188
[TBL] [Abstract][Full Text] [Related]
27. The effect on HDL cholesterol of oxprenolol and atenolol.
Kjeldsen SE; Eide I; Leren P; Foss OP; Holme I; Eriksen IL
Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
[TBL] [Abstract][Full Text] [Related]
28. Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin.
Niutta E; Cusi D; Colombo R; Pellizzoni M; Cesana B; Barlassina C; Soldati L; Bianchi G
J Hypertens Suppl; 1990 Sep; 8(4):S53-8. PubMed ID: 2175354
[TBL] [Abstract][Full Text] [Related]
29. Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension.
McGrath BP; Beilin LJ; Schofield T; Benedict CR; Barker NP; Cooper R
Aust N Z J Med; 1979 Aug; 9(4):374-81. PubMed ID: 389223
[TBL] [Abstract][Full Text] [Related]
30. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
[TBL] [Abstract][Full Text] [Related]
31. [Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes (author's transl)].
Shen JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 1981 Jun; 9(2):94-8. PubMed ID: 7032869
[No Abstract] [Full Text] [Related]
32. [Effect of nifedipine on effective renal plasma flow, plasma renin activity and serum aldosterone, noradrenaline and adrenaline levels in healthy persons and in patients with primary moderate arterial hypertension].
Halawa B; Mazurek W
Pol Tyg Lek; 1989 Jul 23-30; 44(30-31):707-9. PubMed ID: 2701747
[TBL] [Abstract][Full Text] [Related]
33. [Plasma adrenaline and noradrenaline in essential and renal hypertension (author's transl)].
Skrabal F; Auböck J; Hörtnagl H; von Brücke T
Wien Klin Wochenschr; 1981 May; 93(10):321-5. PubMed ID: 7020260
[TBL] [Abstract][Full Text] [Related]
34. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
[TBL] [Abstract][Full Text] [Related]
35. Beta-adrenoceptors and the regulation of blood pressure and plasma renin during exercise.
Hespel P; Lijnen P; Vanhees L; Fagard R; Amery A
J Appl Physiol (1985); 1986 Jan; 60(1):108-13. PubMed ID: 3003020
[TBL] [Abstract][Full Text] [Related]
36. [Short term treatment of essential arterial hypertension with atenolol: effect on the renin-angiotensin-aldosterone system and on hemodynamic parameters].
Indovina I; Salerno L; Licata G; Pepe S; Custro N
Clin Ter; 1983 Feb; 104(3):223-6. PubMed ID: 6861459
[No Abstract] [Full Text] [Related]
37. [Atenolol (Tenormin) in the treatment of hypertension].
Kawecka-Jaszcz K; Kocemba J
Pol Tyg Lek; 1977 Dec; 32(50):1979-81. PubMed ID: 600850
[No Abstract] [Full Text] [Related]
38. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
[TBL] [Abstract][Full Text] [Related]
39. Effects of atenolol on blood pressure, heart rate, renin, and norepinephrine during exercise.
Winer N; Mason WD; Carter CH; Willoughby TL; Kochak GM; Cohen I; Bell RM
Clin Pharmacol Ther; 1979 Sep; 26(3):315-25. PubMed ID: 466925
[No Abstract] [Full Text] [Related]
40. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
